Literature DB >> 9057993

The contribution of transporter-dependent uptake to fetal catecholamine clearance.

L Bzoskie1, L Blount, K Kashiwai, J Humme, J F Padbury.   

Abstract

These studies were designed to determine the contribution of cocaine-sensitive, transporter-dependent, reuptake mechanisms to the intrauterine norepinephrine clearance rate in chronically catheterized fetal sheep. Baseline norepinephrine clearance and appearance rates were 125 +/- 20 ml/kg/min and 85 +/- 11 ng/kg/min, respectively. Transporter-dependent clearance represented 40% of the intrauterine clearance rate. The effects of chronic cocaine administration on fetal catecholamine clearance and appearance rate were then determined in animals treated with daily infusion of saline or cocaine. The total intrauterine clearance rate and the transport-dependent component of intrauterine clearance decreased significantly following the week of drug or placebo treatment, p < 0.05. This was associated with a threefold increase in circulating catecholamine concentrations in both groups of animals, p < 0.05. These results demonstrate that intrauterine catecholamine clearance is highly dependent on transporter-dependent mechanisms. Chronic intrauterine stress, manifested by increased circulating norepinephrine, is associated with a significant decrease in norepinephrine clearance and may be important in the pathogenesis of the adverse effects of stress on the fetus and of drugs like cocaine, which block catecholamine reuptake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057993     DOI: 10.1159/000244403

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  9 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.

Authors:  Huiping Zhang; Graeme N Smith; Xudong Liu; Jeanette J A Holden
Journal:  Physiol Genomics       Date:  2010-03-23       Impact factor: 3.107

Review 3.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

4.  Islet adaptations in fetal sheep persist following chronic exposure to high norepinephrine.

Authors:  Xiaochuan Chen; Amy C Kelly; Dustin T Yates; Antoni R Macko; Ronald M Lynch; Sean W Limesand
Journal:  J Endocrinol       Date:  2016-11-25       Impact factor: 4.286

Review 5.  Hormonal programming across the lifespan.

Authors:  B M Nugent; S A Tobet; H E Lara; A B Lucion; M E Wilson; S E Recabarren; A H Paredes
Journal:  Horm Metab Res       Date:  2012-06-14       Impact factor: 2.936

6.  Enhanced insulin secretion responsiveness and islet adrenergic desensitization after chronic norepinephrine suppression is discontinued in fetal sheep.

Authors:  Xiaochuan Chen; Alice S Green; Antoni R Macko; Dustin T Yates; Amy C Kelly; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-19       Impact factor: 4.310

7.  Prenatal cocaine exposure related to cortisol stress reactivity in 11-year-old children.

Authors:  Barry M Lester; Linda L Lagasse; Seetha Shankaran; Henrietta S Bada; Charles R Bauer; Richard Lin; Abhik Das; Rosemary Higgins
Journal:  J Pediatr       Date:  2010-04-18       Impact factor: 4.406

8.  Functional characterization of dopamine and norepinephrine transport across the apical and basal plasma membranes of the human placental syncytiotrophoblast.

Authors:  Hana Horackova; Rona Karahoda; Veronika Vachalova; Helena Turkova; Cilia Abad; Frantisek Staud
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

9.  Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin during Pregnancy.

Authors:  Nora Lee; Mary F Hebert; David J Wagner; Thomas R Easterling; C Jason Liang; Kenneth Rice; Joanne Wang
Journal:  Mol Pharmacol       Date:  2018-07-16       Impact factor: 4.436

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.